Robert Lipetz
Impact in
- Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Musculoskeletal pain and rehabilitation
Papers in
-
- Attention Deficit Hyperactivity Disorder 3
-
- Inflammatory mediators and NSAID effects 2
- Musculoskeletal pain and rehabilitation 1
- Co-authors
- Douglas K. Kelsey (2 shared papers)Joachim Wernicke (1 shared paper)Humberto Quintana (1 shared paper)Haitao Gao (1 shared paper)Douglas E. Faries (1 shared paper)Donald A. Girod (1 shared paper)Jeffrey W. Brown (1 shared paper)David Michelson (1 shared paper)
- Journals
- Journal of Child and Adolescent Psychopharmacology (2 papers)Clinical Therapeutics (1 paper)Scandinavian Journal of Rheumatology (1 paper)Drug Safety (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Robert Lipetz
7 papers receiving 354 citations
Peers
Comparison fields: 5 of 61
- Psychiatry and Mental health 200
- Pharmacology 128
- Cognitive Neuroscience 76
- Biochemistry 28
- Cardiology and Cardiovascular Medicine 64
Countries citing papers authored by Robert Lipetz
This map shows the geographic impact of Robert Lipetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lipetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lipetz more than expected).
Fields of papers citing papers by Robert Lipetz
This network shows the impact of papers produced by Robert Lipetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lipetz. The network helps show where Robert Lipetz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lipetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 145 | |
| 2 | 2004 | 78 | |
| 3 | 2005 | 53 | |
| 4 | 2007 | 50 | |
| 5 | 2006 | 41 | |
| 6 | 2007 | 13 | |
| 7 | 2012 | 1 |
About Robert Lipetz
Robert Lipetz is a scholar working on Psychiatry and Mental health, Pharmacology, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Surgery, having authored 7 papers that have together received 381 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (3 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmaceutical studies and practices (2 papers), Diabetes Management and Research (1 paper), Pain Mechanisms and Treatments (1 paper), Musculoskeletal pain and rehabilitation (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Psychiatry and Mental health (200 citations), Pharmacology (128 citations), Cognitive Neuroscience (76 citations), Biochemistry (28 citations) and Cardiology and Cardiovascular Medicine (64 citations). Robert Lipetz has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Douglas K. Kelsey, Joachim Wernicke, Humberto Quintana, Haitao Gao, Douglas E. Faries, Donald A. Girod, Jeffrey W. Brown, David Michelson, John H. Heiligenstein and Alan Kivitz. Their work appears in journals such as Journal of Child and Adolescent Psychopharmacology, Clinical Therapeutics, Scandinavian Journal of Rheumatology, Drug Safety and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.